(PharmaNewsWire.Com, January 13, 2018 ) According to the report " Latin America Protein Labelling Market By Product (Reagents, Kits And Services), Labelling Method (In Vitro Labelling, In Vivo Labelling), Application (Cell-Based Assay, Mass Spectroscopy, Fluorescence Microscopy, Immunological Technique, Protein Microarray), End Users & Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016â€“2021)" published by Market Data Forecast, the Latin America Protein Labelling Market was worth USD 0.15 billion in 2016 and estimated to be growing at a CAGR of 8.98%, to reach USD 0.23 billion by 2021.
Protein labelling is done using labelling reagents and kits to label an antibody or other protein, to make an enzyme conjugate, fluorescent probe, biotinylated binding reagent or iodine-labelled tracer for detecting proteins in tissues, cells, and biochemical assays.
R&D enabled the protein labelling market to come up with technologically advance and innovative products, applications and services. R&D is the key strategy adopted by key players of Protein Labelling Market. Exploration through R&D is expected to improve protein tagging technology and enhance higher resolution microscopy. The adoption of IT automation has eased the research and development and expected to boost experimentation and research. Technological advancement and innovation in Protein Labelling market such as computer-controlled systems for fluorescence and laser-confocal microscopy are creating scope for the market.
Growth in demand for customized protein, rise in the prevalence of chronic diseases such as cancer, the need for prevention, diagnosis, and treatment of such diseases is on the rise. Increasing healthcare expenditure, rising R&D spending, and increasing proteomics research are also driving the market. Alternatively, lack of skilled professionals, limited applications of protein labelling products along with high costs of reagents, kits, and other protein labelling services are the key factors that could impede the market growth.
The Latin America Protein Labelling market is categorized by Product, Labelling method, Application and End users. On the basis of Product, the market is segmented into Reagents, Kits and Services. The Labelling segments include In vitro Labelling and In vivo Labelling. On the basis of Application, the market is further segmented into Cell-Based Assay, Mass Spectroscopy, Fluorescence Microscopy, Immunological Technique and Protein Microarray.
Latin America market region includes countries such as Brazil, Mexico, Argentina, and remaining countries of South America. The huge rise in spending in the healthcare division has increased the demand for Protein labelling. Brazil is one of the largest markets in this region followed by Mexico, Argentina, and Columbia, which are also intensifying their investments in the Protein labelling market. The Latin America has a global share of 12% and has a CAGR of 8.98%.
The Key companies dominating the Latin America protein labelling market are Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Eurogentec S.A., PerkinElmer, Inc., F. Hoffmann-La Roche AG, New England Biolabs, Kaneka Corporation, Kirkegaard & Perry Laboratories, Promega Corporation, LI-COR, Inc. and SeraCare Life Sciences, Inc.
About Market Data Forecast Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: